Neuropharmacology of compulsive eating

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 373, Issue 1742, 2018, Pages

  Moore, Catherine F ^a   Panciera, Julia I ^a,b   Sabino, Valentina ^a   Cottone, Pietro ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Addiction; Compulsive; Eating; Habit; Inhibitory control; Withdrawal

Indexed keywords

BEHAVIORAL RESPONSE; HUMAN BEHAVIOR; INHIBITION; NERVOUS SYSTEM; OBESITY; PSYCHOLOGY;

FOOD ADDICTION; HUMAN; NEUROPHARMACOLOGY; PATHOPHYSIOLOGY;

FOOD ADDICTION; HUMANS; NEUROPHARMACOLOGY;

EID: 85040948898     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2017.0024     Document Type: Review

References (125)

1. Compulsive (n.d.). In Merriam-Webster’s online dictionary (11th ed.). Retrieved from http://www. merriam-webster.com/dictionary/compulsive.
2. Moore CF, Sabino V, Koob GF, Cottone P. 2017 pathological overeating: emerging evidence for a compulsivity construct. Neuropsychopharmacology 42, 1375–1389. (doi:10.1038/npp.2016.269)
3. Davis C. 2013 From passive overeating to ‘food addiction’: a spectrum of compulsion and severity. ISRN Obes. 2013, 435027. (doi:10.1155/2013/435027)
4. Volkow ND, Wang GJ, Tomasi D, Baler RD. 2013 The addictive dimensionality of obesity. Biol. Psychiatry 73, 811–818. (doi:10.1016/j.biopsych. 2012.12.020)
5. World Health Organization. 2000 Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series. 894, i-xii, 1–253.
6. Hill JO, Wyatt HR, Reed GW, Peters JC. 2003 Obesity and the environment: where do we go from here? Science 299, 853–855. (doi:10.1126/science. 1079857)
7. American Psychiatric Association. 2013 Diagnostic and statistical manual of mental disorders, 5th edn. Washington, DC: American Psychiatric Association.
8. Gearhardt AN, Corbin WR, Brownell KD. 2009 Preliminary validation of the Yale food addiction scale. Appetite 52, 430–436. (doi:10.1016/j.appet. 2008.12.003)
9. Gearhardt AN, Corbin WR, Brownell KD. 2016 Development of the Yale food addiction scale version 2.0. Psychol. Addict. Behav. 30, 113–121. (doi:10.1037/adb0000136)
10. Dingemans AE, van Furth EF. 2012 Binge eating disorder psychopathology in normal weight and obese individuals. Int. J. Eat. Disord. 45, 135–138. (doi:10.1002/eat.20905)
11. Kessler RC et al. 2013 The prevalence and correlates of binge eating disorder in the world health organization world mental health surveys. Biol. Psychiatry 73, 904–914. (doi:10.1016/j.biopsych. 2012.11.020)
12. Davis C, Curtis C, Levitan RD, Carter JC, Kaplan AS, Kennedy JL. 2011 Evidence that ’food addiction’ is a valid phenotype of obesity. Appetite 57, 711–717. (doi:10.1016/j.appet.2011.08.017)
13. Pursey KM, Stanwell P, Gearhardt AN, Collins CE, Burrows TL. 2014 The prevalence of food addiction as assessed by the Yale food addiction scale: a systematic review. Nutrients 6, 4552–4590. (doi:10. 3390/nu6104552)
14. Everitt BJ, Robbins TW. 2005 Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481–1489. (doi:10.1038/nn1579)
15. Everitt BJ, Robbins TW. 2016 Drug addiction: updating actions to habits to compulsions ten years on. Annu. Rev. Psychol. 67, 23–50. (doi:10.1146/annurev-psych-122414-033457)
16. Koob GF, Volkow ND. 2010 Neurocircuitry of addiction. Neuropsychopharmacology 35, 217–238. (doi:10.1038/npp.2009.110)
17. Parylak SL, Koob GF, Zorrilla EP. 2011 The dark side of food addiction. Physiol. Behav. 104, 149–156. (doi:10.1016/j.physbeh.2011.04.063)
18. el-Guebaly N, Mudry T, Zohar J, Tavares H, Potenza MN. 2012 Compulsive features in behavioural addictions: the case of pathological gambling. Addiction 107, 1726–1734. (doi:10.1111/j.1360-0443.2011.03546.x)
19. Abramowitz JS, Jacoby RJ. 2015 Obsessive-compulsive and related disorders: a critical review of the new diagnostic class. Annu. Rev. Clin. Psychol. 11, 165–186. (doi:10.1146/annurev-clinpsy-032813-153713)
20. Cottone P et al. 2009 CRF system recruitment mediates dark side of compulsive eating. Proc. Natl Acad. Sci. USA 106, 20 016–20 020. (doi:10.1073/pnas.0908789106)
21. Iemolo A, Valenza M, Tozier L, Knapp CM, Kornetsky C, Steardo L, Sabino V, Cottone P. 2012 Withdrawal from chronic, intermittent access to a highly palatable food induces depressive-like behavior in compulsive eating rats. Behav. Pharmacol. 23, 593–602. (doi:10.1097/FBP.0b013e328357697f)
22. Teegarden SL, Bale TL. 2007 Decreases in dietary preference produce increased emotionality and risk for dietary relapse. Biol. Psychiatry 61, 1021–1029. (doi:10.1016/j.biopsych.2006.09.032)
23. Smith KL, Rao RR, Velazquez-Sanchez C, Valenza M, Giuliano C, Everitt BJ, Sabino V, Cottone P. 2015 The uncompetitive N-methyl-D-Aspartate antagonist memantine reduces binge-like eating, food-seeking behavior, and compulsive eating: role of the nucleus accumbens shell. Neuropsychopharmacology 40, 1163–1171. (doi:10.1038/npp.2014.299)
24. Velazquez-Sanchez C, Ferragud A, Moore CF, Everitt BJ, Sabino V, Cottone P. 2014 High trait impulsivity predicts food addiction-like behavior in the rat. Neuropsychopharmacology 39, 2463–2472. (doi:10. 1038/npp.2014.98)
25. Rossetti C, Spena G, Halfon O, Boutrel B. 2014 Evidence for a compulsive-like behavior in rats exposed to alternate access to highly preferred palatable food. Addict. Biol. 19, 975–985. (doi:10. 1111/adb.12065)
26. Koob GF, Volkow ND. 2016 Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3, 760–773. (doi:10.1016/S2215-0366(16)00104-8)
27. Yin HH, Knowlton BJ. 2006 The role of the basal ganglia in habit formation. Nat. Rev. Neurosci. 7, 464–476. (doi:10.1038/nrn1919)
28. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. 2007 D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30, 228–235. (doi:10.1016/j.tins.2007.03.008)
29. Furlong TM, Jayaweera HK, Balleine BW, Corbit LH. 2014 Binge-like consumption of a palatable food accelerates habitual control of behavior and is dependent on activation of the dorsolateral striatum. J. Neurosci. 34, 5012–5022. (doi:10.1523/JNEUROSCI.3707-13.2014)
30. Volkow ND, Wang GJ, Tomasi D, Baler RD. 2013 Unbalanced neuronal circuits in addiction. Curr. Opin Neurobiol. 23, 639–648. (doi:10.1016/j.conb.2013. 01.002)
31. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusll N, Fowler JS. 2001 Brain dopamine and obesity. Lancet 357, 354–357. (doi:10.1016/S0140-6736(00)03643-6)
32. Volkow ND et al. 2008 Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 42, 1537–1543. (doi:10.1016/j. neuroimage.2008.06.002)
33. van de Giessen E, Celik F, Schweitzer DH, van den Brink W, Booij J. 2014 Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. J. Psychopharmacol. 28, 866–873. (doi:10.1177/0269881114531664)
34. Stice E, Spoor S, Bohon C, Small DM. 2008 Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 322, 449–452. (doi:10.1126/science.1161550)
35. Valenza M, Steardo L, Cottone P, Sabino V. 2015 Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of D-amphetamine. Psychopharmacology 232, 3215–3226. (doi:10.1007/s00213-015-3981-3)
36. Johnson PM, Kenny PJ. 2010 Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat. Neurosci. 13, 635–641. (doi:10.1038/nn.2519)
37. Heal DJ, Goddard S, Brammer RJ, Hutson PH, Vickers SP. 2016 Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model. J. Psychopharmacol. 30, 662–675. (doi:10.1177/0269881116647506)
38. McElroy SL, Mitchell JE, Wilfley D, Gasior M, Ferreira-Cornwell MC, McKay M, Wang J, Whitaker T, Hudson JI. 2016 Lisdexamfetamine dimesylate effects on binge eating behaviour and obsessive-compulsive and impulsive features in adults with binge eating disorder. Eur. Eat. Disord. Rev. 24, 223–231. (doi:10.1002/erv.2418)
39. Rowley HL, Kulkarni R, Gosden J, Brammer R, Hackett D, Heal DJ. 2012 Lisdexamfetamine and immediate release d-amfetamine - differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity. Neuropharmacology 63, 1064–1074. (doi:10.1016/j. neuropharm.2012.07.008)
40. Tomasi D, Volkow ND. 2013 Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Crit. Rev. Biochem. Mol. Biol. 48, 1–19. (doi:10.3109/10409238.2012.735642)
41. Volkow ND, Wise RA. 2005 How can drug addiction help us understand obesity? Nat. Neurosci. 8, 555–560. (doi:10.1038/nn1452)
42. Noble EP, Gottschalk LA, Fallon JH, Ritchie TL, Wu JC. 1997 D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am. J. Med. Genet. 74, 162–166. (doi:10.1002/(SICI)1096-8628(19970418)74:2<162::AID-AJMG9>3.0.CO;2-W)
43. Heal DJ, Cheetham SC, Smith SL. 2009 The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 57, 608–618. (doi:10.1016/j.neuropharm.2009.08.020)
44. Laurent V, Morse AK, Balleine BW. 2015 The role of opioid processes in reward and decision-making. Br. J. Pharmacol. 172, 449–459. (doi:10.1111/bph.12818)
45. Giuliano C, Cottone P. 2015 The role of the opioid system in binge eating disorder. CNS Spectr. 20, 537–545. (doi:10.1017/S1092852915000668)
46. Wassum KM, Cely IC, Maidment NT, Balleine BW. 2009 Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition. Neuroscience 163, 770–780. (doi:10. 1016/j.neuroscience.2009.06.071)
47. Corbit LH. 2016 Effects of obesogenic diets on learning and habitual responding. Curr. Opin. Behav. Sci. 9, 84–90. (doi:10.1016/j.cobeha.2016.02.010)
48. Chamberlain SR et al. 2012 Effects of mu opioid receptor antagonism on cognition in obese binge- eating individuals. Psychopharmacology 224, 501–509. (doi:10.1007/s00213-012-2778-x)
49. de Zwaan M, Mitchell JE. 1992 Opiate antagonists and eating behavior in humans: a review. J. Clin. Pharmacol. 32, 1060–1072.
50. Murray E, Brouwer S, McCutcheon R, Harmer CJ, Cowen PJ, McCabe C. 2014 Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity. Psychopharmacology 231, 4323–4335. (doi:10. 1007/s00213-014-3573-7)
51. Alger SA, Schwalberg MD, Bigaouette JM, Michalek AV, Howard LJ. 1991 Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am. J. Clin. Nutr. 53, 865–871.
52. Greenway FL, Dunayevich E, Tollefson G, Erickson J, Guttadauria M, Fujioka K, Cowley MA. 2009 Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. J. Clin. Endocrinol. Metab. 94, 4898–4906. (doi:10. 1210/jc.2009-1350)
53. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E. 2010 Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 376, 595–605. (doi:10.1016/S0140-6736(10)60888-4)
54. Hoebel BG, Avena NM, Bocarsly ME, Rada P. 2009 Natural addiction: a behavioral and circuit model based on sugar addiction in rats. J. Addict. Med. 3, 33–41. (doi:10.1097/ADM.0b013e31819aa621)
55. Colantuoni C, Rada P, McCarthy J, Patten C, Avena NM, Chadeayne A, Hoebel BG. 2002 Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes. Res. 10, 478–488. (doi:10.1038/oby.2002.66)
56. Mena JD, Sadeghian K, Baldo BA. 2011 Induction of hyperphagia and carbohydrate intake by mu-opioid receptor stimulation in circumscribed regions of frontal cortex. J. Neurosci. 31, 3249–3260. (doi:10. 1523/JNEUROSCI.2050-10.2011)
57. Selleck RA, Lake C, Estrada V, Riederer J, Andrzejewski M, Sadeghian K, Baldo BA. 2015 Endogenous opioid signaling in the medial prefrontal cortex is required for the expression of hunger-induced impulsive action. Neuropsychopharmacology 40, 2464–2474. (doi:10. 1038/npp.2015.97)
58. Selleck RA, Baldo BA. 2017 Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens. Psychopharmacology 234, 1439–1449. (doi:10. 1007/s00213-016-4522-4)
59. Cottone P et al. 2012 Antagonism of sigma-1 receptors blocks compulsive-like eating. Neuropsychopharmacology 37, 2593–2604. (doi:10. 1038/npp.2012.89)
60. Blasio A, Steardo L, Sabino V, Cottone P. 2014 Opioid system in the medial prefrontal cortex mediates binge-like eating. Addict. Biol. 19, 652–662. (doi:10.1111/adb.12033)
61. Iemolo A, Blasio A, St Cyr SA, Jiang F, Rice KC, Sabino V, Cottone P. 2013 CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food. Neuropsychopharmacology 38, 2456–2466. (doi:10.1038/npp.2013.147)
62. Zorrilla EP, Logrip ML, Koob GF. 2014 Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol. 35, 234–244. (doi:10.1016/j.yfrne.2014.01.001)
63. Cottone P, Sabino V, Steardo L, Zorrilla EP. 2008 Intermittent access to preferred food reduces the reinforcing efficacy of chow in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1066–R1076. (doi:10.1152/ajpregu.90309.2008)
64. Cottone P, Sabino V, Steardo L, Zorrilla EP. 2009 Consummatory, anxiety-related and metabolic adaptations in female rats with alternating access to preferred food. Psychoneuroendocrinology 34, 38–49. (doi:10.1016/j.psyneuen.2008.08.010)
65. Micioni Di Bonaventura MV et al. 2014 Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction. J. Neurosci. 34, 11 316–11 324. (doi:10.1523/JNEUROSCI.1854-14.2014)
66. Calvez J, de Avila C, Guevremont G, Timofeeva E. 2016 Stress differentially regulates brain expression of corticotropin-releasing factor in binge-like eating prone and resistant female rats. Appetite 107, 585–595. (doi:10.1016/j.appet.2016. 09.010)
67. Epstein DH, Kennedy AP, Furnari M, Heilig M, Shaham Y, Phillips KA, Preston KL. 2016 Effect of the CRF1-receptor antagonist pexacerfont on stress-induced eating and food craving. Psychopharmacology 233, 3921–3932. (doi:10. 1007/s00213-016-4424-5)
68. Spierling SR, Zorrilla EP. 2017 Don’t stress about CRF: assessing the translational failures of CRF1antagonists. Psychopharmacology 234, 1467–1481. (doi:10.1007/s00213-017-4556-2)
69. Koob GF, Zorrilla EP. 2012 Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view. Neuropsychopharmacology 37, 308–309. (doi:10. 1038/npp.2011.213)
70. Koob GF. 2015 The dark side of emotion: the addiction perspective. Eur. J. Pharmacol. 753, 73–87. (doi:10.1016/j.ejphar.2014.11.044)
71. Patel S, Cravatt BF, Hillard CJ. 2005 Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. Neuropsychopharmacology 30, 497–507. (doi:10.1038/sj.npp.1300535)
72. Blasio A et al. 2013 Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. Neuropsychopharmacology 38, 2498–2507. (doi:10.1038/npp.2013.153)
73. Blasio A, Rice KC, Sabino V, Cottone P. 2014 Characterization of a shortened model of diet alternation in female rats: effects of the CB1 receptor antagonist rimonabant on food intake and anxiety-like behavior. Behav. Pharmacol. 25, 609–617. (doi:10.1097/FBP.0000000000000059)
74. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup AV. 2007 A meta-analysis of the efficacy and safety of the anti-obesity agent Rimonabant. Ugeskr. Laeger. 169, 4360–4363.
75. Dore R, Valenza M, Wang X, Rice KC, Sabino V, Cottone P. 2014 The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food. Addict. Biol. 19, 849–861. (doi:10.1111/adb.12056)
76. Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP, Witkin JM, Nomikos GG. 2003 The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br. J. Pharmacol. 138, 544–553. (doi:10. 1038/sj.bjp.0705100)
77. Brennan BP, Roberts JL, Fogarty KV, Reynolds KA, Jonas JM, Hudson JI. 2008 Memantine in the treatment of binge eating disorder: an open-label, prospective trial. Int. J. Eat. Disord. 41, 520–526. (doi:10.1002/eat.20541)
78. Grant JE, Odlaug BL, Mooney M, O’Brien R, Kim SW. 2012 Open-label pilot study of memantine in the treatment of compulsive buying. Ann. Clin. Psychiatry 24, 119–126.
79. Brog JS, Salyapongse A, Deutch AY, Zahm DS. 1993 The patterns of afferent innervation of the core and shell in the ‘accumbens’ part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold. J. Comp. Neurol. 338, 255–278. (doi:10.1002/cne. 903380209)
80. McGeorge AJ, Faull RL. 1989 The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29, 503–537. (doi:10.1016/0306-4522(89)90128-0)
81. Zahm DS, Brog JS. 1992 On the significance of subterritories in the ‘accumbens’ part of the rat ventral striatum. Neuroscience 50, 751–767. (doi:10.1016/0306-4522(92)90202-D)
82. Brown RM et al. 2015 Addiction-like synaptic impairments in diet-induced obesity. Biol. Psychiatry 81, 797–806. (doi:10.1016/j.biopsych.2015.11.019)
83. Gipson CD, Kupchik YM, Kalivas PW. 2014 Rapid, transient synaptic plasticity in addiction. Neuropharmacology 76, 276–286. (doi:10.1016/j. neuropharm.2013.04.032)
84. Valenza M, DiLeo A, Steardo L, Cottone P, Sabino V. 2016 Ethanol-related behaviors in mice lacking the sigma-1 receptor. Behav. Brain Res. 297, 196–203. (doi:10.1016/j.bbr.2015.10.013)
85. Sabino V, Hicks C, Cottone P. 2017 Sigma receptors and substance use disorders. Adv. Exp. Med. Biol. 964, 177–199. (doi:10.1007/978-3-319-50174-1_13)
86. Sabino V, Cottone P. 2016 Sigma receptors and alcohol use disorders. Handb. Exp. Pharmacol. 244, 219–236. (doi:10.1007/164_2016_97)
87. Katz JL, Su TP, Hiranita T, Hayashi T, Tanda G, Kopajtic T, Tsai S-Y. 2011 A role for sigma receptors in stimulant self administration and addiction. Pharmaceuticals 4, 880–914. (doi:10.3390/ph4060880)
88. Blasio A, Valenza M, Iyer MR, Rice KC, Steardo L, Hayashi T, Cottone P, Sabino V. 2015 Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats. Behav. Brain Res. 287, 315–322. (doi:10.1016/j. bbr.2015.03.065)
89. Sabino V, Cottone P, Blasio A, Iyer MR, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP. 2011 Activation of sigma-receptors induces binge-like drinking in Sardinian alcohol-preferring rats. Neuropsychopharmacology 36, 1207–1218. (doi:10. 1038/npp.2011.5)
90. Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RR. 2012 Sigma-1 receptors: potential targets for the treatment of substance abuse. Curr. Pharm. Des 18, 902–919. (doi:10.2174/138161212799436601)
91. Bastianetto S, Rouquier L, Perrault G, Sanger DJ. 1995 DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigro-striatal dopaminergic pathways. Neuropharmacology 34, 281–287. (doi:10.1016/0028-3908(94)00156-M)
92. Dong LY, Cheng ZX, Fu YM, Wang ZM, Zhu YH, Sun JL, Dong Y, Zheng P. 2007 Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor. Neuropharmacology 52, 966– 974. (doi:10.1016/j.neuropharm.2006.10.015)
93. Rada PV, Mark GP, Taylor KM, Hoebel BG. 1996 Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex. Pharmacol. Biochem. Behav. 53, 809–816. (doi:10.1016/0091-3057(95)02078-0)
94. Avena NM, Bocarsly ME, Rada P, Kim A, Hoebel BG. 2008 After daily bingeing on a sucrose solution, food deprivation induces anxiety and accumbens dopamine/acetylcholine imbalance. Physiol. Behav. 94, 309–315. (doi:10.1016/j.physbeh. 2008.01.008)
95. Hernandez L, Hoebel BG. 1988 Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 42, 1705–1712. (doi:10.1016/0024-3205(88)90036-7)
96. Hoebel BG, Avena NM, Rada P. 2007 Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr. Opin Pharmacol. 7, 617–627. (doi:10.1016/j.coph.2007.10.014)
97. Mark GP, Shabani S, Dobbs LK, Hansen ST. 2011 Cholinergic modulation of mesolimbic dopamine function and reward. Physiol. Behav. 104, 76–81. (doi:10.1016/j.physbeh.2011.04.052)
98. Borowsky B et al. 2001 Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc. Natl Acad. Sci. USA 98, 8966–8971. (doi:10.1073/pnas.151105198)
99. Grandy DK, Miller GM, Li JX. 2016 ‘TAARgeting addiction’–the alamo bears witness to another revolution: an overview of the plenary symposium of the 2015 behavior, biology and chemistry conference. Drug Alcohol Depend. 159, 9–16. (doi:10.1016/j.drugalcdep.2015.11.014)
100. Espinoza S et al. 2015 TAAR1 modulates cortical glutamate NMDA receptor function. Neuropsychopharmacology 40, 2217–2227. (doi:10. 1038/npp.2015.65)
101. Ferragud A, Howell AD, Moore CF, Ta TL, Hoener MC, Sabino V, Cottone P. 2016 The trace amine-associated receptor 1 agonist RO5256390 blocks compulsive, binge-like eating in rats.Neuropsychopharmacology 42, 1458–1470. (doi:10. 1038/npp.2016.233)
102. Goodman DW. 2010 Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/ hyperactivity disorder. Pharm. Ther. 35, 273–287.
103. Jimerson DC, Lesem MD, Kaye WH, Brewerton TD. 1992 Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch. Gen. Psychiatry 49, 132–138. (doi:10.1001/archpsyc. 1992.01820020052007)
104. Fineberg NA, Roberts A, Montgomery SA, Cowen PJ. 1997 Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine. Br. J. Psychiatry 171, 280–282. (doi:10.1192/bjp. 171.3.280)
105. Steiger H, Israel M, Gauvin L, Ng Ying Kin NM, Young SN. 2003 Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa. Psychiatry Res. 120, 219–229. (doi:10.1016/S0165-1781(03)00195-1)
106. De Fanti BA, Gavel DA, Hamilton JS, Horwitz BA. 2000 Extracellular hypothalamic serotonin levels after dorsal raphe nuclei stimulation of lean (Fa/Fa) and obese (fa/fa) Zucker rats. Brain Res. 869, 6–14. (doi:10.1016/S0006-8993(00)02308-8)
107. Ratner C, Ettrup A, Bueter M, Haahr ME, Compan V, le Roux CW, Levin B, Hansen HH, Knudsen GM. 2012 Cerebral markers of the serotonergic system in rat models of obesity and after Roux-en-Y gastric bypass. Obesity 20, 2133–2141. (doi:10.1038/oby.2012.75)
108. Kuikka JT et al. 2001 Reduced serotonin transporter binding in binge eating women. Psychopharmacology 155, 310–314. (doi:10.1007/s002130100716)
109. McElroy SL, Guerdjikova AI, Mori N, Keck Jr PE. 2015 Psychopharmacologic treatment of eating disorders: emerging findings. Curr. Psychiatry Rep. 17, 35. (doi:10.1007/s11920-015-0573-1)
110. Milano W, Petrella C, Casella A, Capasso A, Carrino S, Milano L. 2005 Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study. Adv. Ther. 22, 25–31. (doi:10. 1007/BF02850181)
111. Steiger H, Gauvin L, Engelberg MJ, Ying Kin NM, Israel M, Wonderlich SA, Richardson J. 2005 Mood-and restraint-based antecedents to binge episodes in bulimia nervosa: possible influences of the serotonin system. Psychol. Med. 35, 1553–1562. (doi:10.1017/S0033291705005817)
112. Xu P et al. 2017 Activation of serotonin 2C receptors in dopamine neurons inhibits binge-like eating in mice. Biol. Psychiatry 81, 737–747. (doi:10.1016/j. biopsych.2016.06.005)
113. Valencia-Torres L, Olarte-Sanchez CM, Lyons DJ, Georgescu T, Greenwald-Yarnell M, Myers Jr MG, Bradshaw CM, Heisler LK. 2017 Activation of ventral tegmental area 5-HT2C receptors reduces incentive motivation. Neuropsychopharmacology 42, 1511–1521. (doi:10.1038/npp.2016.264)
114. Hernandez L, Lee F, Hoebel BG. 1987 Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin. Brain Res. Bull. 19, 623–628. (doi:10. 1016/0361-9230(87)90047-5)
115. Boutrel B, de Lecea L. 2008 Addiction and arousal: the hypocretin connection. Physiol. Behav. 93, 947–951. (doi:10.1016/j.physbeh.2007.11.022)
116. Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. 2010 Role of orexin/ hypocretin in reward-seeking and addiction: implications for obesity. Physiol. Behav. 100, 419–428. (doi:10.1016/j.physbeh.2010.03.009)
117. Piccoli L et al. 2012 Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology 37, 1999–2011. (doi:10. 1038/npp.2012.48)
118. Alcaraz-Iborra M, Carvajal F, Lerma-Cabrera JM, Valor LM, Cubero I. 2014 Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6 J mice: pharmacological and molecular evidence of orexin involvement. Behav. Brain Res. 272, 93–99. (doi:10.1016/j.bbr. 2014.06.049)
119. Petrovich GD, Hobin MP, Reppucci CJ. 2012 Selective Fos induction in hypothalamic orexin/hypocretin, but not melanin-concentrating hormone neurons, by a learned food-cue that stimulates feeding in sated rats. Neuroscience 224, 70–80. (doi:10.1016/j. neuroscience.2012.08.036)
120. Campbell EJ, Barker DJ, Nasser HM, Kaganovsky K, Dayas CV, Marchant NJ. 2017 Cue-induced food seeking after punishment is associated with increased Fos expression in the lateral hypothalamus and basolateral and medial amygdala. Behav. Neurosci. 131, 155–167. (doi:10. 1037/bne0000185)
121. Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV. 2014 Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front. Neurosci. 8, 36. (doi:10.3389/fnins. 2014.00036)
122. Pankevich DE, Teegarden SL, Hedin AD, Jensen CL, Bale TL. 2010 Caloric restriction experience reprograms stress and orexigenic pathways and promotes binge eating. J. Neurosci. 30, 16 399– 16 407. (doi:10.1523/JNEUROSCI.1955-10.2010)
123. Shalev U. 2012 Chronic food restriction augments the reinstatement of extinguished heroin-seeking behavior in rats. Addict. Biol. 17, 691–693. (doi:10. 1111/j.1369-1600.2010.00303.x)
124. Carr KD. 2016 Nucleus accumbens AMPA receptor trafficking upregulated by food restriction: an unintended target for drugs of abuse and forbidden foods. Curr. Opin. Behav. Sci. 9, 32–39. (doi:10. 1016/j.cobeha.2015.11.019)
125. Karlsson HK, Tuominen L, Tuulari JJ, Hirvonen J, Parkkola R, Helin S, Salminen P, Nuutila P, Nummenmaa L. 2015 Obesity is associated with decreased mu-opioid but unaltered dopamine D2 receptor availability in the brain. J. Neurosci. 35, 3959–3965. (doi:10.1523/JNEUROSCI.4744-14.2015)